nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroflumethiazide—CA9—breast cancer	0.588	1	CbGaD
Hydroflumethiazide—CA5B—mammary gland—breast cancer	0.00264	0.0426	CbGeAlD
Hydroflumethiazide—ATP1A1—mammary gland—breast cancer	0.00197	0.0318	CbGeAlD
Hydroflumethiazide—SLC12A1—epithelium—breast cancer	0.00188	0.0304	CbGeAlD
Hydroflumethiazide—SLC12A3—female reproductive system—breast cancer	0.00183	0.0296	CbGeAlD
Hydroflumethiazide—KCNMA1—epithelium—breast cancer	0.00171	0.0276	CbGeAlD
Hydroflumethiazide—CA9—female reproductive system—breast cancer	0.00164	0.0266	CbGeAlD
Hydroflumethiazide—ATP1A1—nipple—breast cancer	0.00163	0.0263	CbGeAlD
Hydroflumethiazide—CA14—adrenal gland—breast cancer	0.00152	0.0246	CbGeAlD
Hydroflumethiazide—CA4—nipple—breast cancer	0.0015	0.0243	CbGeAlD
Hydroflumethiazide—KCNMA1—uterus—breast cancer	0.00141	0.0228	CbGeAlD
Hydroflumethiazide—CA9—endocrine gland—breast cancer	0.00139	0.0225	CbGeAlD
Hydroflumethiazide—KCNMA1—adipose tissue—breast cancer	0.00138	0.0223	CbGeAlD
Hydroflumethiazide—ATP1A1—embryo—breast cancer	0.00134	0.0217	CbGeAlD
Hydroflumethiazide—KCNMA1—female reproductive system—breast cancer	0.00127	0.0205	CbGeAlD
Hydroflumethiazide—CA2—nipple—breast cancer	0.00125	0.0202	CbGeAlD
Hydroflumethiazide—KCNMA1—adrenal gland—breast cancer	0.00124	0.02	CbGeAlD
Hydroflumethiazide—CA12—female reproductive system—breast cancer	0.00122	0.0196	CbGeAlD
Hydroflumethiazide—CA5B—adipose tissue—breast cancer	0.00119	0.0192	CbGeAlD
Hydroflumethiazide—ATP1A1—epithelium—breast cancer	0.0011	0.0177	CbGeAlD
Hydroflumethiazide—CA5B—female reproductive system—breast cancer	0.00109	0.0176	CbGeAlD
Hydroflumethiazide—KCNMA1—endocrine gland—breast cancer	0.00107	0.0173	CbGeAlD
Hydroflumethiazide—CA5B—adrenal gland—breast cancer	0.00106	0.0172	CbGeAlD
Hydroflumethiazide—CA1—adipose tissue—breast cancer	0.00105	0.0169	CbGeAlD
Hydroflumethiazide—ATP1A1—skin of body—breast cancer	0.00104	0.0169	CbGeAlD
Hydroflumethiazide—CA2—embryo—breast cancer	0.00103	0.0166	CbGeAlD
Hydroflumethiazide—CA12—endocrine gland—breast cancer	0.00103	0.0166	CbGeAlD
Hydroflumethiazide—ATP1A1—endometrium—breast cancer	0.000983	0.0159	CbGeAlD
Hydroflumethiazide—CA1—female reproductive system—breast cancer	0.000963	0.0156	CbGeAlD
Hydroflumethiazide—CA5B—endocrine gland—breast cancer	0.000923	0.0149	CbGeAlD
Hydroflumethiazide—Hydrochlorothiazide—CA9—breast cancer	0.000922	0.529	CrCbGaD
Hydroflumethiazide—CA1—bone marrow—breast cancer	0.000909	0.0147	CbGeAlD
Hydroflumethiazide—ATP1A1—uterus—breast cancer	0.000906	0.0146	CbGeAlD
Hydroflumethiazide—ATP1A1—pituitary gland—breast cancer	0.00089	0.0144	CbGeAlD
Hydroflumethiazide—ATP1A1—adipose tissue—breast cancer	0.000886	0.0143	CbGeAlD
Hydroflumethiazide—CA2—epithelium—breast cancer	0.00084	0.0136	CbGeAlD
Hydroflumethiazide—Trichlormethiazide—CA9—breast cancer	0.000822	0.471	CrCbGaD
Hydroflumethiazide—CA4—pituitary gland—breast cancer	0.000822	0.0133	CbGeAlD
Hydroflumethiazide—CA4—adipose tissue—breast cancer	0.000819	0.0132	CbGeAlD
Hydroflumethiazide—CA1—endocrine gland—breast cancer	0.000815	0.0132	CbGeAlD
Hydroflumethiazide—ATP1A1—female reproductive system—breast cancer	0.000814	0.0132	CbGeAlD
Hydroflumethiazide—CA2—skin of body—breast cancer	0.000799	0.0129	CbGeAlD
Hydroflumethiazide—ATP1A1—adrenal gland—breast cancer	0.000795	0.0128	CbGeAlD
Hydroflumethiazide—ATP1A1—bone marrow—breast cancer	0.000769	0.0124	CbGeAlD
Hydroflumethiazide—CA4—female reproductive system—breast cancer	0.000752	0.0122	CbGeAlD
Hydroflumethiazide—KCNMA1—lymph node—breast cancer	0.000741	0.012	CbGeAlD
Hydroflumethiazide—ATP1A1—female gonad—breast cancer	0.000741	0.012	CbGeAlD
Hydroflumethiazide—CA4—adrenal gland—breast cancer	0.000734	0.0119	CbGeAlD
Hydroflumethiazide—CA4—bone marrow—breast cancer	0.00071	0.0115	CbGeAlD
Hydroflumethiazide—ATP1A1—endocrine gland—breast cancer	0.000689	0.0111	CbGeAlD
Hydroflumethiazide—CA4—female gonad—breast cancer	0.000685	0.0111	CbGeAlD
Hydroflumethiazide—CA2—pituitary gland—breast cancer	0.000682	0.011	CbGeAlD
Hydroflumethiazide—CA2—adipose tissue—breast cancer	0.000679	0.011	CbGeAlD
Hydroflumethiazide—CA5B—lymph node—breast cancer	0.000638	0.0103	CbGeAlD
Hydroflumethiazide—CA4—endocrine gland—breast cancer	0.000637	0.0103	CbGeAlD
Hydroflumethiazide—CA2—female reproductive system—breast cancer	0.000624	0.0101	CbGeAlD
Hydroflumethiazide—CA2—adrenal gland—breast cancer	0.000609	0.00984	CbGeAlD
Hydroflumethiazide—CA2—bone marrow—breast cancer	0.000589	0.00952	CbGeAlD
Hydroflumethiazide—CA2—female gonad—breast cancer	0.000568	0.00918	CbGeAlD
Hydroflumethiazide—CA1—lymph node—breast cancer	0.000563	0.0091	CbGeAlD
Hydroflumethiazide—CA2—endocrine gland—breast cancer	0.000528	0.00854	CbGeAlD
Hydroflumethiazide—ATP1A1—lymph node—breast cancer	0.000476	0.0077	CbGeAlD
Hydroflumethiazide—CA4—lymph node—breast cancer	0.00044	0.00712	CbGeAlD
Hydroflumethiazide—CA2—lymph node—breast cancer	0.000365	0.0059	CbGeAlD
Hydroflumethiazide—Anorexia—Vinorelbine—breast cancer	0.000341	0.00173	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Methotrexate—breast cancer	0.00034	0.00173	CcSEcCtD
Hydroflumethiazide—Asthenia—Chlorambucil—breast cancer	0.000337	0.00171	CcSEcCtD
Hydroflumethiazide—Aplastic anaemia—Doxorubicin—breast cancer	0.000335	0.0017	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Thiotepa—breast cancer	0.000334	0.0017	CcSEcCtD
Hydroflumethiazide—Urticaria—Tamoxifen—breast cancer	0.000332	0.00169	CcSEcCtD
Hydroflumethiazide—Anorexia—Thiotepa—breast cancer	0.000326	0.00166	CcSEcCtD
Hydroflumethiazide—Urticaria—Melphalan—breast cancer	0.000325	0.00166	CcSEcCtD
Hydroflumethiazide—Vertigo—Irinotecan—breast cancer	0.000325	0.00165	CcSEcCtD
Hydroflumethiazide—Leukopenia—Irinotecan—breast cancer	0.000323	0.00165	CcSEcCtD
Hydroflumethiazide—Leukopenia—Mitoxantrone—breast cancer	0.000323	0.00165	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Chlorambucil—breast cancer	0.000321	0.00164	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Epirubicin—breast cancer	0.000319	0.00162	CcSEcCtD
Hydroflumethiazide—Urticaria—Goserelin—breast cancer	0.000317	0.00161	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vinblastine—breast cancer	0.000317	0.00161	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Capecitabine—breast cancer	0.000317	0.00161	CcSEcCtD
Hydroflumethiazide—Leukopenia—Gemcitabine—breast cancer	0.000315	0.0016	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Capecitabine—breast cancer	0.000313	0.00159	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Epirubicin—breast cancer	0.000313	0.00159	CcSEcCtD
Hydroflumethiazide—Jaundice—Docetaxel—breast cancer	0.000312	0.00159	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Vinorelbine—breast cancer	0.000311	0.00158	CcSEcCtD
Hydroflumethiazide—Leukopenia—Fluorouracil—breast cancer	0.00031	0.00158	CcSEcCtD
Hydroflumethiazide—Asthenia—Vinblastine—breast cancer	0.000309	0.00157	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Tamoxifen—breast cancer	0.000308	0.00157	CcSEcCtD
Hydroflumethiazide—Constipation—Vinorelbine—breast cancer	0.000306	0.00156	CcSEcCtD
Hydroflumethiazide—Jaundice—Capecitabine—breast cancer	0.000302	0.00154	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Melphalan—breast cancer	0.000302	0.00153	CcSEcCtD
Hydroflumethiazide—Asthenia—Tamoxifen—breast cancer	0.0003	0.00153	CcSEcCtD
Hydroflumethiazide—Vomiting—Chlorambucil—breast cancer	0.000299	0.00152	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Docetaxel—breast cancer	0.000298	0.00152	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Thiotepa—breast cancer	0.000297	0.00151	CcSEcCtD
Hydroflumethiazide—Photosensitivity—Doxorubicin—breast cancer	0.000295	0.0015	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vinblastine—breast cancer	0.000294	0.0015	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Goserelin—breast cancer	0.000294	0.0015	CcSEcCtD
Hydroflumethiazide—Asthenia—Melphalan—breast cancer	0.000294	0.00149	CcSEcCtD
Hydroflumethiazide—Constipation—Thiotepa—breast cancer	0.000292	0.00149	CcSEcCtD
Hydroflumethiazide—Purpura—Epirubicin—breast cancer	0.00029	0.00148	CcSEcCtD
Hydroflumethiazide—Vascular purpura—Doxorubicin—breast cancer	0.000289	0.00147	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Capecitabine—breast cancer	0.000289	0.00147	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Irinotecan—breast cancer	0.000289	0.00147	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Mitoxantrone—breast cancer	0.000289	0.00147	CcSEcCtD
Hydroflumethiazide—Asthenia—Goserelin—breast cancer	0.000286	0.00146	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Tamoxifen—breast cancer	0.000286	0.00146	CcSEcCtD
Hydroflumethiazide—Dizziness—Vinblastine—breast cancer	0.000285	0.00145	CcSEcCtD
Hydroflumethiazide—Urticaria—Vinorelbine—breast cancer	0.000284	0.00145	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Paclitaxel—breast cancer	0.000283	0.00144	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Gemcitabine—breast cancer	0.000281	0.00143	CcSEcCtD
Hydroflumethiazide—Anorexia—Irinotecan—breast cancer	0.000281	0.00143	CcSEcCtD
Hydroflumethiazide—Anorexia—Mitoxantrone—breast cancer	0.000281	0.00143	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Melphalan—breast cancer	0.00028	0.00143	CcSEcCtD
Hydroflumethiazide—Nausea—Chlorambucil—breast cancer	0.000279	0.00142	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Fluorouracil—breast cancer	0.000277	0.00141	CcSEcCtD
Hydroflumethiazide—Dizziness—Tamoxifen—breast cancer	0.000276	0.00141	CcSEcCtD
Hydroflumethiazide—Anorexia—Gemcitabine—breast cancer	0.000274	0.00139	CcSEcCtD
Hydroflumethiazide—Vomiting—Vinblastine—breast cancer	0.000274	0.00139	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Goserelin—breast cancer	0.000273	0.00139	CcSEcCtD
Hydroflumethiazide—Urticaria—Thiotepa—breast cancer	0.000271	0.00138	CcSEcCtD
Hydroflumethiazide—Agitation—Paclitaxel—breast cancer	0.000271	0.00138	CcSEcCtD
Hydroflumethiazide—Headache—Vinblastine—breast cancer	0.00027	0.00137	CcSEcCtD
Hydroflumethiazide—Anorexia—Fluorouracil—breast cancer	0.000269	0.00137	CcSEcCtD
Hydroflumethiazide—Purpura—Doxorubicin—breast cancer	0.000269	0.00137	CcSEcCtD
Hydroflumethiazide—Vomiting—Tamoxifen—breast cancer	0.000266	0.00135	CcSEcCtD
Hydroflumethiazide—Vertigo—Paclitaxel—breast cancer	0.000265	0.00135	CcSEcCtD
Hydroflumethiazide—Dizziness—Goserelin—breast cancer	0.000264	0.00134	CcSEcCtD
Hydroflumethiazide—Leukopenia—Paclitaxel—breast cancer	0.000264	0.00134	CcSEcCtD
Hydroflumethiazide—Rash—Tamoxifen—breast cancer	0.000264	0.00134	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Vinorelbine—breast cancer	0.000263	0.00134	CcSEcCtD
Hydroflumethiazide—Dermatitis—Tamoxifen—breast cancer	0.000263	0.00134	CcSEcCtD
Hydroflumethiazide—Headache—Tamoxifen—breast cancer	0.000262	0.00133	CcSEcCtD
Hydroflumethiazide—Vomiting—Melphalan—breast cancer	0.00026	0.00132	CcSEcCtD
Hydroflumethiazide—Rash—Melphalan—breast cancer	0.000258	0.00131	CcSEcCtD
Hydroflumethiazide—Dermatitis—Melphalan—breast cancer	0.000258	0.00131	CcSEcCtD
Hydroflumethiazide—Asthenia—Vinorelbine—breast cancer	0.000257	0.00131	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Mitoxantrone—breast cancer	0.000256	0.0013	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Irinotecan—breast cancer	0.000256	0.0013	CcSEcCtD
Hydroflumethiazide—Nausea—Vinblastine—breast cancer	0.000256	0.0013	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Epirubicin—breast cancer	0.000256	0.0013	CcSEcCtD
Hydroflumethiazide—Vomiting—Goserelin—breast cancer	0.000254	0.00129	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Methotrexate—breast cancer	0.000253	0.00129	CcSEcCtD
Hydroflumethiazide—Constipation—Mitoxantrone—breast cancer	0.000252	0.00128	CcSEcCtD
Hydroflumethiazide—Constipation—Irinotecan—breast cancer	0.000252	0.00128	CcSEcCtD
Hydroflumethiazide—Rash—Goserelin—breast cancer	0.000252	0.00128	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Thiotepa—breast cancer	0.000252	0.00128	CcSEcCtD
Hydroflumethiazide—Dermatitis—Goserelin—breast cancer	0.000251	0.00128	CcSEcCtD
Hydroflumethiazide—Headache—Goserelin—breast cancer	0.00025	0.00127	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Gemcitabine—breast cancer	0.00025	0.00127	CcSEcCtD
Hydroflumethiazide—Nausea—Tamoxifen—breast cancer	0.000248	0.00126	CcSEcCtD
Hydroflumethiazide—Constipation—Gemcitabine—breast cancer	0.000246	0.00125	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Fluorouracil—breast cancer	0.000246	0.00125	CcSEcCtD
Hydroflumethiazide—Asthenia—Thiotepa—breast cancer	0.000245	0.00125	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Vinorelbine—breast cancer	0.000245	0.00125	CcSEcCtD
Hydroflumethiazide—Nausea—Melphalan—breast cancer	0.000243	0.00124	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Docetaxel—breast cancer	0.00024	0.00122	CcSEcCtD
Hydroflumethiazide—Nausea—Goserelin—breast cancer	0.000237	0.00121	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Epirubicin—breast cancer	0.000237	0.00121	CcSEcCtD
Hydroflumethiazide—Dizziness—Vinorelbine—breast cancer	0.000236	0.0012	CcSEcCtD
Hydroflumethiazide—Orthostatic hypotension—Doxorubicin—breast cancer	0.000236	0.0012	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Methotrexate—breast cancer	0.000236	0.0012	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Paclitaxel—breast cancer	0.000235	0.0012	CcSEcCtD
Hydroflumethiazide—Urticaria—Mitoxantrone—breast cancer	0.000234	0.00119	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Thiotepa—breast cancer	0.000234	0.00119	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Capecitabine—breast cancer	0.000233	0.00118	CcSEcCtD
Hydroflumethiazide—Anorexia—Paclitaxel—breast cancer	0.000229	0.00117	CcSEcCtD
Hydroflumethiazide—Vomiting—Vinorelbine—breast cancer	0.000227	0.00116	CcSEcCtD
Hydroflumethiazide—Dizziness—Thiotepa—breast cancer	0.000226	0.00115	CcSEcCtD
Hydroflumethiazide—Rash—Vinorelbine—breast cancer	0.000225	0.00115	CcSEcCtD
Hydroflumethiazide—Dermatitis—Vinorelbine—breast cancer	0.000225	0.00115	CcSEcCtD
Hydroflumethiazide—Urticaria—Fluorouracil—breast cancer	0.000224	0.00114	CcSEcCtD
Hydroflumethiazide—Headache—Vinorelbine—breast cancer	0.000224	0.00114	CcSEcCtD
Hydroflumethiazide—Leukopenia—Docetaxel—breast cancer	0.000224	0.00114	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Epirubicin—breast cancer	0.000221	0.00112	CcSEcCtD
Hydroflumethiazide—Pancreatitis—Doxorubicin—breast cancer	0.000219	0.00112	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Epirubicin—breast cancer	0.000218	0.00111	CcSEcCtD
Hydroflumethiazide—Vertigo—Capecitabine—breast cancer	0.000217	0.00111	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Irinotecan—breast cancer	0.000217	0.00111	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Mitoxantrone—breast cancer	0.000217	0.00111	CcSEcCtD
Hydroflumethiazide—Vomiting—Thiotepa—breast cancer	0.000217	0.00111	CcSEcCtD
Hydroflumethiazide—Leukopenia—Capecitabine—breast cancer	0.000216	0.0011	CcSEcCtD
Hydroflumethiazide—Rash—Thiotepa—breast cancer	0.000215	0.0011	CcSEcCtD
Hydroflumethiazide—Dermatitis—Thiotepa—breast cancer	0.000215	0.00109	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Methotrexate—breast cancer	0.000215	0.00109	CcSEcCtD
Hydroflumethiazide—Headache—Thiotepa—breast cancer	0.000214	0.00109	CcSEcCtD
Hydroflumethiazide—Nausea—Vinorelbine—breast cancer	0.000212	0.00108	CcSEcCtD
Hydroflumethiazide—Asthenia—Irinotecan—breast cancer	0.000212	0.00108	CcSEcCtD
Hydroflumethiazide—Asthenia—Mitoxantrone—breast cancer	0.000212	0.00108	CcSEcCtD
Hydroflumethiazide—Jaundice—Epirubicin—breast cancer	0.00021	0.00107	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Paclitaxel—breast cancer	0.000209	0.00106	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Fluorouracil—breast cancer	0.000208	0.00106	CcSEcCtD
Hydroflumethiazide—Asthenia—Gemcitabine—breast cancer	0.000206	0.00105	CcSEcCtD
Hydroflumethiazide—Constipation—Paclitaxel—breast cancer	0.000206	0.00105	CcSEcCtD
Hydroflumethiazide—Photosensitivity reaction—Doxorubicin—breast cancer	0.000204	0.00104	CcSEcCtD
Hydroflumethiazide—Nausea—Thiotepa—breast cancer	0.000203	0.00103	CcSEcCtD
Hydroflumethiazide—Hyperglycaemia—Doxorubicin—breast cancer	0.000202	0.00103	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Mitoxantrone—breast cancer	0.000202	0.00103	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Irinotecan—breast cancer	0.000202	0.00103	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Epirubicin—breast cancer	0.000201	0.00102	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Docetaxel—breast cancer	0.0002	0.00102	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Gemcitabine—breast cancer	0.000197	0.001	CcSEcCtD
Hydroflumethiazide—Dizziness—Irinotecan—breast cancer	0.000195	0.000993	CcSEcCtD
Hydroflumethiazide—Jaundice—Doxorubicin—breast cancer	0.000194	0.00099	CcSEcCtD
Hydroflumethiazide—Anorexia—Docetaxel—breast cancer	0.000194	0.000989	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Fluorouracil—breast cancer	0.000193	0.000984	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Capecitabine—breast cancer	0.000193	0.000984	CcSEcCtD
Hydroflumethiazide—Urticaria—Paclitaxel—breast cancer	0.000191	0.000973	CcSEcCtD
Hydroflumethiazide—Anorexia—Capecitabine—breast cancer	0.000188	0.000958	CcSEcCtD
Hydroflumethiazide—Vomiting—Mitoxantrone—breast cancer	0.000188	0.000954	CcSEcCtD
Hydroflumethiazide—Vomiting—Irinotecan—breast cancer	0.000188	0.000954	CcSEcCtD
Hydroflumethiazide—Dizziness—Fluorouracil—breast cancer	0.000187	0.000951	CcSEcCtD
Hydroflumethiazide—Agranulocytosis—Doxorubicin—breast cancer	0.000186	0.000948	CcSEcCtD
Hydroflumethiazide—Rash—Irinotecan—breast cancer	0.000186	0.000946	CcSEcCtD
Hydroflumethiazide—Rash—Mitoxantrone—breast cancer	0.000186	0.000946	CcSEcCtD
Hydroflumethiazide—Dermatitis—Mitoxantrone—breast cancer	0.000186	0.000946	CcSEcCtD
Hydroflumethiazide—Dermatitis—Irinotecan—breast cancer	0.000186	0.000946	CcSEcCtD
Hydroflumethiazide—Headache—Irinotecan—breast cancer	0.000185	0.00094	CcSEcCtD
Hydroflumethiazide—Headache—Mitoxantrone—breast cancer	0.000185	0.00094	CcSEcCtD
Hydroflumethiazide—Vomiting—Gemcitabine—breast cancer	0.000183	0.00093	CcSEcCtD
Hydroflumethiazide—Rash—Gemcitabine—breast cancer	0.000181	0.000922	CcSEcCtD
Hydroflumethiazide—Dermatitis—Gemcitabine—breast cancer	0.000181	0.000921	CcSEcCtD
Hydroflumethiazide—Headache—Gemcitabine—breast cancer	0.00018	0.000916	CcSEcCtD
Hydroflumethiazide—Vomiting—Fluorouracil—breast cancer	0.00018	0.000914	CcSEcCtD
Hydroflumethiazide—Rash—Fluorouracil—breast cancer	0.000178	0.000906	CcSEcCtD
Hydroflumethiazide—Dermatitis—Fluorouracil—breast cancer	0.000178	0.000906	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Docetaxel—breast cancer	0.000177	0.000902	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Paclitaxel—breast cancer	0.000177	0.000902	CcSEcCtD
Hydroflumethiazide—Headache—Fluorouracil—breast cancer	0.000177	0.000901	CcSEcCtD
Hydroflumethiazide—Nausea—Mitoxantrone—breast cancer	0.000175	0.000892	CcSEcCtD
Hydroflumethiazide—Nausea—Irinotecan—breast cancer	0.000175	0.000892	CcSEcCtD
Hydroflumethiazide—Constipation—Docetaxel—breast cancer	0.000174	0.000887	CcSEcCtD
Hydroflumethiazide—Asthenia—Paclitaxel—breast cancer	0.000173	0.000878	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Capecitabine—breast cancer	0.000172	0.000873	CcSEcCtD
Hydroflumethiazide—Nausea—Gemcitabine—breast cancer	0.000171	0.000869	CcSEcCtD
Hydroflumethiazide—Constipation—Capecitabine—breast cancer	0.000169	0.000859	CcSEcCtD
Hydroflumethiazide—Nausea—Fluorouracil—breast cancer	0.000168	0.000854	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Paclitaxel—breast cancer	0.000165	0.000838	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Epirubicin—breast cancer	0.000162	0.000825	CcSEcCtD
Hydroflumethiazide—Vertigo—Methotrexate—breast cancer	0.000162	0.000823	CcSEcCtD
Hydroflumethiazide—Leukopenia—Methotrexate—breast cancer	0.000161	0.00082	CcSEcCtD
Hydroflumethiazide—Dizziness—Paclitaxel—breast cancer	0.000159	0.00081	CcSEcCtD
Hydroflumethiazide—Urticaria—Capecitabine—breast cancer	0.000157	0.000798	CcSEcCtD
Hydroflumethiazide—Agitation—Epirubicin—breast cancer	0.000155	0.000788	CcSEcCtD
Hydroflumethiazide—Vomiting—Paclitaxel—breast cancer	0.000153	0.000778	CcSEcCtD
Hydroflumethiazide—Rash—Paclitaxel—breast cancer	0.000152	0.000772	CcSEcCtD
Hydroflumethiazide—Dermatitis—Paclitaxel—breast cancer	0.000152	0.000771	CcSEcCtD
Hydroflumethiazide—Vertigo—Epirubicin—breast cancer	0.000151	0.00077	CcSEcCtD
Hydroflumethiazide—Leukopenia—Epirubicin—breast cancer	0.000151	0.000768	CcSEcCtD
Hydroflumethiazide—Headache—Paclitaxel—breast cancer	0.000151	0.000767	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Docetaxel—breast cancer	0.00015	0.000765	CcSEcCtD
Hydroflumethiazide—Muscle spasms—Doxorubicin—breast cancer	0.00015	0.000763	CcSEcCtD
Hydroflumethiazide—Asthenia—Docetaxel—breast cancer	0.000146	0.000745	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Capecitabine—breast cancer	0.000145	0.00074	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Methotrexate—breast cancer	0.000144	0.000732	CcSEcCtD
Hydroflumethiazide—Agitation—Doxorubicin—breast cancer	0.000143	0.000729	CcSEcCtD
Hydroflumethiazide—Nausea—Paclitaxel—breast cancer	0.000143	0.000727	CcSEcCtD
Hydroflumethiazide—Asthenia—Capecitabine—breast cancer	0.000142	0.000721	CcSEcCtD
Hydroflumethiazide—Vertigo—Doxorubicin—breast cancer	0.00014	0.000713	CcSEcCtD
Hydroflumethiazide—Anorexia—Methotrexate—breast cancer	0.00014	0.000713	CcSEcCtD
Hydroflumethiazide—Leukopenia—Doxorubicin—breast cancer	0.00014	0.00071	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Docetaxel—breast cancer	0.000139	0.00071	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Capecitabine—breast cancer	0.000135	0.000687	CcSEcCtD
Hydroflumethiazide—Dizziness—Docetaxel—breast cancer	0.000135	0.000686	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Epirubicin—breast cancer	0.000135	0.000685	CcSEcCtD
Hydroflumethiazide—Anorexia—Epirubicin—breast cancer	0.000131	0.000667	CcSEcCtD
Hydroflumethiazide—Dizziness—Capecitabine—breast cancer	0.000131	0.000664	CcSEcCtD
Hydroflumethiazide—Vomiting—Docetaxel—breast cancer	0.00013	0.00066	CcSEcCtD
Hydroflumethiazide—Rash—Docetaxel—breast cancer	0.000129	0.000654	CcSEcCtD
Hydroflumethiazide—Dermatitis—Docetaxel—breast cancer	0.000128	0.000654	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Methotrexate—breast cancer	0.000128	0.00065	CcSEcCtD
Hydroflumethiazide—Headache—Docetaxel—breast cancer	0.000128	0.00065	CcSEcCtD
Hydroflumethiazide—Vomiting—Capecitabine—breast cancer	0.000125	0.000639	CcSEcCtD
Hydroflumethiazide—Thrombocytopenia—Doxorubicin—breast cancer	0.000125	0.000634	CcSEcCtD
Hydroflumethiazide—Rash—Capecitabine—breast cancer	0.000124	0.000633	CcSEcCtD
Hydroflumethiazide—Dermatitis—Capecitabine—breast cancer	0.000124	0.000633	CcSEcCtD
Hydroflumethiazide—Headache—Capecitabine—breast cancer	0.000124	0.000629	CcSEcCtD
Hydroflumethiazide—Anorexia—Doxorubicin—breast cancer	0.000121	0.000617	CcSEcCtD
Hydroflumethiazide—Nausea—Docetaxel—breast cancer	0.000121	0.000616	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Epirubicin—breast cancer	0.00012	0.000608	CcSEcCtD
Hydroflumethiazide—Constipation—Epirubicin—breast cancer	0.000118	0.000599	CcSEcCtD
Hydroflumethiazide—Nausea—Capecitabine—breast cancer	0.000117	0.000597	CcSEcCtD
Hydroflumethiazide—Urticaria—Methotrexate—breast cancer	0.000117	0.000594	CcSEcCtD
Hydroflumethiazide—Decreased appetite—Doxorubicin—breast cancer	0.000111	0.000563	CcSEcCtD
Hydroflumethiazide—Urticaria—Epirubicin—breast cancer	0.000109	0.000556	CcSEcCtD
Hydroflumethiazide—Constipation—Doxorubicin—breast cancer	0.000109	0.000554	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Methotrexate—breast cancer	0.000108	0.000551	CcSEcCtD
Hydroflumethiazide—Asthenia—Methotrexate—breast cancer	0.000105	0.000537	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Epirubicin—breast cancer	0.000101	0.000516	CcSEcCtD
Hydroflumethiazide—Urticaria—Doxorubicin—breast cancer	0.000101	0.000514	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Methotrexate—breast cancer	0.000101	0.000512	CcSEcCtD
Hydroflumethiazide—Asthenia—Epirubicin—breast cancer	9.87e-05	0.000502	CcSEcCtD
Hydroflumethiazide—Dizziness—Methotrexate—breast cancer	9.72e-05	0.000495	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Epirubicin—breast cancer	9.41e-05	0.000479	CcSEcCtD
Hydroflumethiazide—Hypersensitivity—Doxorubicin—breast cancer	9.37e-05	0.000477	CcSEcCtD
Hydroflumethiazide—Vomiting—Methotrexate—breast cancer	9.34e-05	0.000476	CcSEcCtD
Hydroflumethiazide—Rash—Methotrexate—breast cancer	9.26e-05	0.000472	CcSEcCtD
Hydroflumethiazide—Dermatitis—Methotrexate—breast cancer	9.26e-05	0.000471	CcSEcCtD
Hydroflumethiazide—Headache—Methotrexate—breast cancer	9.2e-05	0.000469	CcSEcCtD
Hydroflumethiazide—Asthenia—Doxorubicin—breast cancer	9.13e-05	0.000465	CcSEcCtD
Hydroflumethiazide—Dizziness—Epirubicin—breast cancer	9.09e-05	0.000463	CcSEcCtD
Hydroflumethiazide—Vomiting—Epirubicin—breast cancer	8.74e-05	0.000445	CcSEcCtD
Hydroflumethiazide—Nausea—Methotrexate—breast cancer	8.73e-05	0.000444	CcSEcCtD
Hydroflumethiazide—Diarrhoea—Doxorubicin—breast cancer	8.7e-05	0.000443	CcSEcCtD
Hydroflumethiazide—Rash—Epirubicin—breast cancer	8.67e-05	0.000441	CcSEcCtD
Hydroflumethiazide—Dermatitis—Epirubicin—breast cancer	8.66e-05	0.000441	CcSEcCtD
Hydroflumethiazide—Headache—Epirubicin—breast cancer	8.61e-05	0.000438	CcSEcCtD
Hydroflumethiazide—Dizziness—Doxorubicin—breast cancer	8.41e-05	0.000428	CcSEcCtD
Hydroflumethiazide—Nausea—Epirubicin—breast cancer	8.17e-05	0.000416	CcSEcCtD
Hydroflumethiazide—Vomiting—Doxorubicin—breast cancer	8.09e-05	0.000412	CcSEcCtD
Hydroflumethiazide—Rash—Doxorubicin—breast cancer	8.02e-05	0.000408	CcSEcCtD
Hydroflumethiazide—Dermatitis—Doxorubicin—breast cancer	8.01e-05	0.000408	CcSEcCtD
Hydroflumethiazide—Headache—Doxorubicin—breast cancer	7.97e-05	0.000406	CcSEcCtD
Hydroflumethiazide—Nausea—Doxorubicin—breast cancer	7.56e-05	0.000385	CcSEcCtD
Hydroflumethiazide—CA2—Metabolism—CYP17A1—breast cancer	3.42e-05	0.000225	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—IL2—breast cancer	3.4e-05	0.000223	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NCOA2—breast cancer	3.4e-05	0.000223	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALDOA—breast cancer	3.39e-05	0.000223	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ENO1—breast cancer	3.39e-05	0.000222	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS1—breast cancer	3.39e-05	0.000222	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CYP1A1—breast cancer	3.39e-05	0.000222	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—MAPK3—breast cancer	3.38e-05	0.000222	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Neuronal System—HRAS—breast cancer	3.36e-05	0.000221	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ERCC2—breast cancer	3.36e-05	0.000221	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ABCB1—breast cancer	3.35e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ABCB1—breast cancer	3.35e-05	0.00022	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP2D6—breast cancer	3.32e-05	0.000218	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—FASN—breast cancer	3.3e-05	0.000217	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOA3—breast cancer	3.29e-05	0.000216	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—COMT—breast cancer	3.29e-05	0.000216	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—TYMS—breast cancer	3.29e-05	0.000216	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—TYMS—breast cancer	3.29e-05	0.000216	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—BCHE—breast cancer	3.28e-05	0.000216	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP17A1—breast cancer	3.28e-05	0.000215	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTP1—breast cancer	3.28e-05	0.000215	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC2A2—breast cancer	3.27e-05	0.000215	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NCOA2—breast cancer	3.26e-05	0.000214	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GSTM1—breast cancer	3.25e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GSTM1—breast cancer	3.25e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NCOR1—breast cancer	3.25e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PLA2G4A—breast cancer	3.25e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NCOR1—breast cancer	3.25e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PLA2G4A—breast cancer	3.25e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ENO1—breast cancer	3.25e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS1—breast cancer	3.25e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC5A5—breast cancer	3.24e-05	0.000213	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—HMOX1—breast cancer	3.23e-05	0.000212	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ITPR1—breast cancer	3.22e-05	0.000212	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MTR—breast cancer	3.2e-05	0.00021	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CPT1A—breast cancer	3.2e-05	0.00021	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCG2—breast cancer	3.2e-05	0.00021	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP2D6—breast cancer	3.18e-05	0.000209	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—FASN—breast cancer	3.16e-05	0.000208	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—MTHFR—breast cancer	3.16e-05	0.000207	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—BCHE—breast cancer	3.15e-05	0.000207	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HPGDS—breast cancer	3.14e-05	0.000206	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NQO1—breast cancer	3.13e-05	0.000206	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—SLC2A1—breast cancer	3.13e-05	0.000206	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NCOA2—breast cancer	3.13e-05	0.000205	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HBA1—breast cancer	3.12e-05	0.000205	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—GPX1—breast cancer	3.11e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—GPX1—breast cancer	3.11e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC5A5—breast cancer	3.11e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ABCB1—breast cancer	3.1e-05	0.000204	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CYP1A1—breast cancer	3.08e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CYP1A1—breast cancer	3.08e-05	0.000202	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ERCC2—breast cancer	3.06e-05	0.000201	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ERCC2—breast cancer	3.06e-05	0.000201	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP3A4—breast cancer	3.06e-05	0.000201	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ACHE—breast cancer	3.05e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—TYMS—breast cancer	3.05e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTT1—breast cancer	3.05e-05	0.0002	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—FASN—breast cancer	3.03e-05	0.000199	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—BCHE—breast cancer	3.02e-05	0.000198	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PLA2G4A—breast cancer	3.01e-05	0.000198	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NCOR1—breast cancer	3.01e-05	0.000198	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GSTM1—breast cancer	3.01e-05	0.000198	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP1B1—breast cancer	3e-05	0.000197	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—SLC2A1—breast cancer	3e-05	0.000197	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NQO1—breast cancer	3e-05	0.000197	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC5A5—breast cancer	2.98e-05	0.000196	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—SRC—breast cancer	2.97e-05	0.000195	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—HSP90AA1—breast cancer	2.95e-05	0.000193	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP3A4—breast cancer	2.93e-05	0.000192	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—CAV1—breast cancer	2.91e-05	0.000191	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—VEGFA—breast cancer	2.89e-05	0.00019	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP17A1—breast cancer	2.88e-05	0.000189	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—GPX1—breast cancer	2.88e-05	0.000189	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NQO1—breast cancer	2.88e-05	0.000189	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—SLC2A1—breast cancer	2.88e-05	0.000189	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP1B1—breast cancer	2.88e-05	0.000189	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—MTHFR—breast cancer	2.87e-05	0.000189	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—MTHFR—breast cancer	2.87e-05	0.000189	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NCOA1—breast cancer	2.87e-05	0.000188	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ENO1—breast cancer	2.85e-05	0.000188	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS1—breast cancer	2.85e-05	0.000188	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CYP1A1—breast cancer	2.85e-05	0.000188	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ERCC2—breast cancer	2.83e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—STK11—breast cancer	2.82e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP19A1—breast cancer	2.82e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—HSP90AA1—breast cancer	2.82e-05	0.000186	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP3A4—breast cancer	2.81e-05	0.000184	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP2D6—breast cancer	2.8e-05	0.000184	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP1B1—breast cancer	2.76e-05	0.000181	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOA2—breast cancer	2.75e-05	0.00018	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NCOA1—breast cancer	2.75e-05	0.00018	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—MAPK3—breast cancer	2.73e-05	0.00018	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—HSP90AA1—breast cancer	2.71e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—STK11—breast cancer	2.71e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP19A1—breast cancer	2.71e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—TP53—breast cancer	2.7e-05	0.000178	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—FASN—breast cancer	2.67e-05	0.000175	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—MTHFR—breast cancer	2.66e-05	0.000175	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—BCHE—breast cancer	2.65e-05	0.000174	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CG—breast cancer	2.65e-05	0.000174	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TGFB1—breast cancer	2.65e-05	0.000174	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—CAV1—breast cancer	2.65e-05	0.000174	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—CAV1—breast cancer	2.65e-05	0.000174	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NCOA1—breast cancer	2.63e-05	0.000173	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—COMT—breast cancer	2.63e-05	0.000172	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC5A5—breast cancer	2.62e-05	0.000172	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTP1—breast cancer	2.61e-05	0.000172	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—STK11—breast cancer	2.6e-05	0.000171	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP19A1—breast cancer	2.6e-05	0.000171	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—HMOX1—breast cancer	2.58e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ITPR1—breast cancer	2.57e-05	0.000169	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NQO1—breast cancer	2.53e-05	0.000166	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—SLC2A1—breast cancer	2.53e-05	0.000166	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—COMT—breast cancer	2.52e-05	0.000165	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTP1—breast cancer	2.51e-05	0.000165	CbGpPWpGaD
Hydroflumethiazide—CA9—Cellular responses to stress—IL6—breast cancer	2.47e-05	0.000162	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ABCB1—breast cancer	2.47e-05	0.000162	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—HMOX1—breast cancer	2.47e-05	0.000162	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP3A4—breast cancer	2.47e-05	0.000162	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ITPR1—breast cancer	2.47e-05	0.000162	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—KRAS—breast cancer	2.46e-05	0.000161	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—CAV1—breast cancer	2.46e-05	0.000161	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—TYMS—breast cancer	2.43e-05	0.00016	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP1B1—breast cancer	2.43e-05	0.000159	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CG—breast cancer	2.41e-05	0.000159	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CG—breast cancer	2.41e-05	0.000159	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—COMT—breast cancer	2.41e-05	0.000159	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTP1—breast cancer	2.4e-05	0.000158	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PLA2G4A—breast cancer	2.4e-05	0.000158	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GSTM1—breast cancer	2.4e-05	0.000158	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NCOR1—breast cancer	2.4e-05	0.000158	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HSP90AA1—breast cancer	2.38e-05	0.000156	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ABCB1—breast cancer	2.37e-05	0.000156	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—HMOX1—breast cancer	2.37e-05	0.000156	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ITPR1—breast cancer	2.36e-05	0.000155	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CD—breast cancer	2.33e-05	0.000153	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—TYMS—breast cancer	2.33e-05	0.000153	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOA1—breast cancer	2.32e-05	0.000152	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GSTM1—breast cancer	2.3e-05	0.000151	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PLA2G4A—breast cancer	2.3e-05	0.000151	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NCOR1—breast cancer	2.3e-05	0.000151	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—ALB—breast cancer	2.3e-05	0.000151	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—GPX1—breast cancer	2.3e-05	0.000151	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—STK11—breast cancer	2.28e-05	0.00015	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP19A1—breast cancer	2.28e-05	0.00015	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CYP1A1—breast cancer	2.28e-05	0.00015	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ABCB1—breast cancer	2.27e-05	0.000149	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ERCC2—breast cancer	2.26e-05	0.000148	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—PIK3CA—breast cancer	2.26e-05	0.000148	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CG—breast cancer	2.24e-05	0.000147	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—TYMS—breast cancer	2.23e-05	0.000147	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PLA2G4A—breast cancer	2.21e-05	0.000145	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NCOR1—breast cancer	2.21e-05	0.000145	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GSTM1—breast cancer	2.21e-05	0.000145	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—GPX1—breast cancer	2.21e-05	0.000145	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—NOS3—breast cancer	2.2e-05	0.000145	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—TP53—breast cancer	2.18e-05	0.000143	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CYP1A1—breast cancer	2.18e-05	0.000143	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ERCC2—breast cancer	2.16e-05	0.000142	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—MTHFR—breast cancer	2.12e-05	0.000139	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CD—breast cancer	2.12e-05	0.000139	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CD—breast cancer	2.12e-05	0.000139	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—COMT—breast cancer	2.12e-05	0.000139	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—GPX1—breast cancer	2.11e-05	0.000139	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTP1—breast cancer	2.11e-05	0.000139	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—ALB—breast cancer	2.09e-05	0.000138	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—ALB—breast cancer	2.09e-05	0.000138	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CYP1A1—breast cancer	2.09e-05	0.000137	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—HRAS—breast cancer	2.09e-05	0.000137	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—HMOX1—breast cancer	2.08e-05	0.000137	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ITPR1—breast cancer	2.08e-05	0.000136	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ERCC2—breast cancer	2.08e-05	0.000136	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—MTHFR—breast cancer	2.03e-05	0.000134	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CB—breast cancer	2.03e-05	0.000134	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTGS2—breast cancer	2.01e-05	0.000132	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—NOS3—breast cancer	2e-05	0.000132	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—NOS3—breast cancer	2e-05	0.000132	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ABCB1—breast cancer	2e-05	0.000131	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CD—breast cancer	1.97e-05	0.000129	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—TYMS—breast cancer	1.96e-05	0.000129	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—CAV1—breast cancer	1.96e-05	0.000129	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—MTHFR—breast cancer	1.95e-05	0.000128	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NCOR1—breast cancer	1.94e-05	0.000127	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PLA2G4A—breast cancer	1.94e-05	0.000127	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GSTM1—breast cancer	1.94e-05	0.000127	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—ALB—breast cancer	1.94e-05	0.000127	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—CAV1—breast cancer	1.88e-05	0.000123	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—GPX1—breast cancer	1.86e-05	0.000122	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—NOS3—breast cancer	1.86e-05	0.000122	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CB—breast cancer	1.85e-05	0.000121	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CB—breast cancer	1.85e-05	0.000121	CbGpPWpGaD
Hydroflumethiazide—KCNMA1—Hemostasis—AKT1—breast cancer	1.84e-05	0.000121	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CYP1A1—breast cancer	1.84e-05	0.000121	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTGS2—breast cancer	1.83e-05	0.00012	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTGS2—breast cancer	1.83e-05	0.00012	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ERCC2—breast cancer	1.82e-05	0.00012	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—CAV1—breast cancer	1.8e-05	0.000118	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CG—breast cancer	1.78e-05	0.000117	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PTEN—breast cancer	1.76e-05	0.000115	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—MTHFR—breast cancer	1.72e-05	0.000113	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CB—breast cancer	1.71e-05	0.000113	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CG—breast cancer	1.71e-05	0.000112	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTGS2—breast cancer	1.7e-05	0.000112	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CG—breast cancer	1.64e-05	0.000108	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PTEN—breast cancer	1.6e-05	0.000105	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PTEN—breast cancer	1.6e-05	0.000105	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—CAV1—breast cancer	1.58e-05	0.000104	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CD—breast cancer	1.57e-05	0.000103	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—ALB—breast cancer	1.55e-05	0.000102	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CD—breast cancer	1.5e-05	9.87e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—ALB—breast cancer	1.48e-05	9.74e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PTEN—breast cancer	1.48e-05	9.72e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—NOS3—breast cancer	1.48e-05	9.72e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CG—breast cancer	1.44e-05	9.46e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CD—breast cancer	1.44e-05	9.46e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—ALB—breast cancer	1.42e-05	9.34e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—NOS3—breast cancer	1.42e-05	9.32e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CB—breast cancer	1.37e-05	8.97e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—NOS3—breast cancer	1.36e-05	8.94e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTGS2—breast cancer	1.35e-05	8.89e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CB—breast cancer	1.31e-05	8.6e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTGS2—breast cancer	1.3e-05	8.53e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CD—breast cancer	1.27e-05	8.32e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CB—breast cancer	1.26e-05	8.25e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—ALB—breast cancer	1.25e-05	8.21e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTGS2—breast cancer	1.24e-05	8.17e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—PIK3CA—breast cancer	1.24e-05	8.14e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—NOS3—breast cancer	1.2e-05	7.86e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PTEN—breast cancer	1.18e-05	7.75e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PTEN—breast cancer	1.13e-05	7.43e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—PIK3CA—breast cancer	1.13e-05	7.41e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—PIK3CA—breast cancer	1.13e-05	7.41e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CB—breast cancer	1.1e-05	7.25e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTGS2—breast cancer	1.09e-05	7.19e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PTEN—breast cancer	1.09e-05	7.13e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—PIK3CA—breast cancer	1.04e-05	6.86e-05	CbGpPWpGaD
Hydroflumethiazide—CA14—Metabolism—AKT1—breast cancer	1.01e-05	6.65e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PTEN—breast cancer	9.54e-06	6.27e-05	CbGpPWpGaD
Hydroflumethiazide—CA7—Metabolism—AKT1—breast cancer	9.21e-06	6.05e-05	CbGpPWpGaD
Hydroflumethiazide—CA5B—Metabolism—AKT1—breast cancer	9.21e-06	6.05e-05	CbGpPWpGaD
Hydroflumethiazide—CA12—Metabolism—AKT1—breast cancer	8.53e-06	5.6e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—PIK3CA—breast cancer	8.33e-06	5.47e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—PIK3CA—breast cancer	7.99e-06	5.24e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—PIK3CA—breast cancer	7.66e-06	5.03e-05	CbGpPWpGaD
Hydroflumethiazide—CA4—Metabolism—AKT1—breast cancer	6.8e-06	4.47e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—PIK3CA—breast cancer	6.73e-06	4.42e-05	CbGpPWpGaD
Hydroflumethiazide—CA2—Metabolism—AKT1—breast cancer	6.52e-06	4.28e-05	CbGpPWpGaD
Hydroflumethiazide—CA1—Metabolism—AKT1—breast cancer	6.25e-06	4.11e-05	CbGpPWpGaD
Hydroflumethiazide—CA9—Metabolism—AKT1—breast cancer	5.5e-06	3.61e-05	CbGpPWpGaD
